Počet záznamov: 1
imatinib mezylát
SYS d000068877 LBL 00000nx^^^2200181-^^45^^ 005 20240119195244.1 100 $a 20160101asloy0103 ba0 152 $b mesh 250 $a imatinib mezylát $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $8 slo 300 1-
$a 2016 (1996) $8 eng 330 1-
$a A tyrosine kinase inhibitor and ANTINEOPLASTIC AGENT that inhibits the BCR-ABL kinase created by chromosome rearrangements in CHRONIC MYELOID LEUKEMIA and ACUTE LYMPHOBLASTIC LEUKEMIA, as well as PDG-derived tyrosine kinases that are overexpressed in gastrointestinal stromal tumors. $8 eng 450 $a CGP 57148 $5 e $8 slo 450 $a imatinib $5 e $8 slo 450 $a imatinib metánsulfonát $5 e $8 slo 450 $a ST 1571 $5 e $8 slo 686 $a D02.065.277.456 686 $a D02.241.223.100.100.435 686 $a D02.455.426.559.389.127.085.465 686 $a D03.383.606.405 686 $a D03.383.742.349 750 $a Imatinib Mesylate $8 eng 801 -0
$a SK $b BA006 $c 20160207 801 -2
$a SK $b BA006 $c 20160215 980 $x M
Počet záznamov: 1